Opioid antagonist detoxification under anaesthesia versus traditional clonidine detoxification combined with an additional week of psychosocial support: a randomised clinical trial

Drug Alcohol Depend. 2006 Feb 1;81(2):109-16. doi: 10.1016/j.drugalcdep.2005.06.003. Epub 2005 Jul 15.

Abstract

Background: While detoxification under anaesthesia accelerates the detoxification procedure, there is a lack of randomised clinical trials evaluating its effectiveness compared to traditional detoxification procedures, and a lack of data on long-term abstinence.

Methods: Prospective randomised clinical trial. Analysis by intention to treat and per protocol.

Setting: Specialised substance abuse unit in a psychiatric teaching hospital and an intensive care unit of a general hospital.

Participants: Seventy patients with opiate mono-dependence requesting detoxification: 36 randomised to RODA (treatment as allocated received by 26) and 34 randomised to classical clonidine detoxification (treatment as allocated received by 21).

Main outcome measures: Successful detoxification, safety and self-reported abstinence at 3, 6 and 12 months after detoxification.

Results: Socio-demographics were similar in both groups at baseline. No complications were reported during or after anaesthesia. According to the intention to treat analysis, 28/36 (78%) RODA patients and 21/34 (62%) of the clonidine group successfully completed the detoxification process (p=0.14). In the intention to treat analysis, 30% of RODA patients were abstinent after 3 months compared to 14% in the clonidine group (p=0.11). No difference was found at 6 and 12 months (both groups showed less than 5% abstinence after 12 months). The per-protocol analysis showed similar results with no statistical differences either for ASI mean scores or for the SF36 questionnaire.

Conclusion: Although the detoxification success rate and abstinence after 3 months were slightly better for the RODA procedure compared to clonidine treatment, these differences were not statistically significant and disappeared completely after 6 and 12 months.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Algorithms
  • Analgesics / therapeutic use*
  • Anesthesia, General
  • Clonidine / therapeutic use*
  • Drug Administration Schedule
  • Female
  • Heroin Dependence / drug therapy*
  • Heroin Dependence / psychology*
  • Hospitals, Psychiatric
  • Hospitals, Teaching
  • Humans
  • Inactivation, Metabolic*
  • Male
  • Naltrexone / therapeutic use*
  • Narcotic Antagonists / therapeutic use*
  • Prospective Studies
  • Recurrence
  • Substance Withdrawal Syndrome / psychology*
  • Time Factors
  • Treatment Outcome

Substances

  • Analgesics
  • Narcotic Antagonists
  • Naltrexone
  • Clonidine